Showing results (121-130 of 193) with videos related to
Sort By:
Pageof 20
Inflammatory Bowel Diseases|January 25, 2025
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLSJessica R Allegretti, Paul Feuerstadt, Whitfield L Knapple, et al.Digestive Diseases and Sciences|July 18, 2021
Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile InfectionPaul Feuerstadt, Olga C Aroniadis, Felicia L Svedlund, et al.Journal of Gastroenterology and Hepatology|December 6, 2017
Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: A national propensity-matched studyParis Charilaou, Kalpit Devani, Febin John, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection FrequencyRaseen Tariq, Darrell S Pardi, Pritish K Tosh, et al.Anaerobe|July 23, 2019
Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysisSrishti Saha, Saloni Kapoor, Raseen Tariq, et al.Journal of Gastroenterology and Hepatology|June 20, 2023
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel diseaseAndree H Koop, Paul M Travers, Sahil Khanna, et al.Infectious Diseases and Therapy|June 12, 2026
Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical StudiesTeena Chopra, Daniel Van Handel, Brian Baggott, et al.The American Journal of Gastroenterology|April 13, 2022
Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile From a Population-Based StudyJune Tome, Kanika Sehgal, Amrit K Kamboj, et al.Plos One|April 10, 2020
Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care quality?Mitchell S von Itzstein, Arjun Gupta, Kemp H Kernstine, et al.Gastro Hep Advances|April 17, 2025
Effects of Oral Anticoagulant and Antiplatelet Agents on Performance of Multitarget Colorectal Cancer Screening TestReilly A Coombs, James L Adkins, Andrew M Turunen, et al.Pageof 20